Atlas Trials

Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer

Clinical trial NCT06527898 · RECRUITING

Trial details

NCT number
NCT06527898
Sponsor
Anhui Provincial Hospital
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Small-cell Lung Cancer
Start date
2024-07-01
Primary completion
2026-07-31
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.